Vistra Corp. (VST)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2.5B 5B 7.5B Q3 '21: 3B Q4 '21: 3.3B Q1 '22: 3.1B Q2 '22: 1.6B Q3 '22: 5.1B Q4 '22: 3.9B Q1 '23: 4.4B Q2 '23: 3.2B Q3 '23: 4.1B Q4 '23: 3.1B Q1 '24: 3.1B Q2 '24: 3.8B Q3 '24: 6.3B Q4 '24: 4B Q1 '25: 3.9B Q2 '25: 4.2B Q3 '25: 5B Q4 '25: 4.6B Q1 '26: 5.6B Q2 '26: 4B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 2B 4B 6B Q3 '21: 2.6B Q4 '21: 2.9B Q1 '22: 2.7B Q2 '22: 1.2B Q3 '22: 4.7B Q4 '22: 3.5B Q1 '23: 4B Q2 '23: 2.7B Q3 '23: 3.7B Q4 '23: 2.7B Q1 '24: 2.6B Q2 '24: 3.2B Q3 '24: 5.7B Q4 '24: 3.4B Q1 '25: 3.2B Q2 '25: 3.5B Q3 '25: 4.3B Q4 '25: 3.9B Q1 '26: 4.9B Q2 '26: 3.2B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-1.8B -900M 0 900M 1.8B 2.7B Q2 '21: 62M Q3 '21: 119M Q1 '22: -288M Q2 '22: -1.7B Q3 '22: 894M Q4 '22: -100M Q1 '23: 1.1B Q2 '23: 591M Q3 '23: 834M Q4 '23: 102M Q1 '24: 86M Q2 '24: 808M Q3 '24: 2.6B Q4 '24: 599M Q1 '25: -120M Q2 '25: 515M Q3 '25: 1B Q4 '25: 474M Q1 '26: 1.5B Q2 '26: 553M Q3 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-2.1B -1.4B -700M 0 700M 1.4B 2.1B Q1 '21: -2B Q2 '21: 36M Q3 '21: 7M Q1 '22: -285M Q2 '22: -1.4B Q3 '22: 668M Q4 '22: -245M Q1 '23: 699M Q2 '23: 476M Q3 '23: 502M Q1 '24: -35M Q2 '24: 365M Q3 '24: 1.9B Q4 '24: 441M Q1 '25: -268M Q2 '25: 327M Q3 '25: 652M Q4 '25: 233M Q1 '26: 1B Q2 '26: 305M Q2 '21 Q2 '22 Q1 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 300M 600M 900M Q3 '21: 372M Q4 '21: 386M Q1 '22: 416M Q2 '22: 435M Q3 '22: 400M Q4 '22: 395M Q1 '23: 421M Q2 '23: 445M Q3 '23: 411M Q4 '23: 425M Q1 '24: 498M Q2 '24: 628M Q3 '24: 616M Q4 '24: 672M Q1 '25: 693M Q2 '25: 733M Q3 '25: 655M Q4 '25: 722M Q1 '26: 700M Q2 '26: 853M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-1.8B -1.2B -600M 0 600M 1.2B 1.8B Q3 '21: 564M Q4 '21: 287M Q1 '22: 591M Q2 '22: -1.3B Q3 '22: 815M Q4 '22: 393M Q1 '23: 1.4B Q2 '23: 1.6B Q3 '23: 1.6B Q4 '23: 881M Q1 '24: 312M Q2 '24: 1.2B Q3 '24: 1.7B Q4 '24: 1.4B Q1 '25: 599M Q2 '25: 572M Q3 '25: 1.5B Q4 '25: 1.4B Q1 '26: 1.2B Q2 '26: 1B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-1.8B -1.2B -600M 0 600M 1.2B 1.8B Q3 '21: 320M Q4 '21: 44M Q1 '22: 218M Q2 '22: -1.6B Q3 '22: 519M Q4 '22: 1M Q1 '23: 951M Q2 '23: 1.1B Q3 '23: 1.2B Q4 '23: 467M Q1 '24: -153M Q2 '24: 698M Q3 '24: 1B Q4 '24: 923M Q1 '25: -169M Q2 '25: -118M Q3 '25: 1B Q4 '25: 596M Q1 '26: 316M Q2 '26: 334M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 200M 400M 600M Q1 '20: 490.6M Q2 '20: 490.5M Q3 '20: 491M Q1 '21: 484.7M Q2 '21: 487.4M Q3 '21: 484.5M Q1 '22: 451.6M Q2 '22: 429.2M Q3 '22: 417.5M Q1 '23: 387.6M Q2 '23: 376.8M Q3 '23: 372.1M Q1 '24: 349M Q2 '24: 354.3M Q3 '24: 350.2M Q1 '25: 339.8M Q2 '25: 345.5M Q3 '25: 345M Q1 '26: 341.9M Q2 '26: 339.2M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-5.00 -2.50 0.00 2.50 5.00 7.50 Q3 '19: 1.02 Q4 '19: 1.86 Q1 '20: 1.53 Q2 '20: 1.17 Q3 '20: 1.84 Q4 '20: 1.30 Q1 '21: -3.02 Q2 '21: -3.29 Q3 '21: -4.18 Q4 '22: -3.26 Q1 '23: -0.83 Q2 '23: 3.61 Q3 '23: 3.35 Q4 '24: 7.05 Q1 '25: 6.36 Q2 '25: 6.27 Q3 '25: 2.77 Q4 '25: 2.17 Q1 '26: 5.97 Q2 '26: 5.92 Q4 '19 Q3 '20 Q2 '21 Q1 '23 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.